Michael Ladd, Pharm.D, RPh

VP, Regulatory Affairs

Dr. Ladd's pharmaceutical career spans over 25 years of clinical and drug development experience across immuno-oncology, cell and gene therapy, infectious disease, and rare disease. He most recently held the role of Vice President, Global Regulatory Affairs at Trevi Therapeutics. Prior to Trevi, Mike was Vice President and Head of Regulatory Affairs at Mural Oncology and Executive Director, Head of Regeneron Cell Medicines - Regulatory Sciences at Regeneron Pharmaceuticals. Before this, he served in regulatory leadership roles at 2seventy bio, where he supported Abecma life cycle management, and Orchard Therapeutics, where he led global strategy for the gene therapy portfolio. Mike began his industry career at BMS, ultimately serving as Director, Medical and Regulatory Affairs – US Oncology, where he led regulatory strategy for OPDIVO approvals across multiple tumor types. He earned his Pharm.D. from the University of Colorado Denver and his B.S. in Pharmacy from the University of Connecticut.